Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 861177 NEW YORK, NY

Position in RIGL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,968
+$6,475 QoQ
Shares Held
536
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#121
of 156 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. RIGL ranks #153 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,968 536
2026-03-31 $14,493 536
2025-12-31 $7,923 185
2022-09-30 $248,485 210,582
2022-06-30 $237,956 210,582
2022-03-31 $629,637 210,582
2021-12-31 $558,041 210,582
2021-09-30 $764,410 210,582
2021-06-30 $1,321,984 304,605
2021-03-31 $1,037,585 303,388
2020-12-31 $1,070,362 305,818
2020-09-30 $227,879 94,950
2020-06-30 $195,271 106,706
2020-03-31 $169,503 108,656